Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
45 studies found for:    "friedreich ataxia"
Show Display Options
Rank Status Study
21 Completed Efficacy Study of Epoetin Alfa in Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: Epoetin alfa;   Drug: Placebo
22 Completed Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Placebo;   Drug: EPI-743 400 mg;   Drug: EPI-743 200 mg
23 Terminated Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: varenicline;   Drug: placebo
24 Recruiting (+) Epicatechin to Treat Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention: Drug: (+)-Epicatechin
25 Completed
Has Results
Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: EGb 761 120 mg;   Drug: Placebo
26 Completed
Has Results
An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: bupropion & Citalopram;   Drug: Bupropion & Placebo;   Drug: Placebo & Citalopram;   Drug: Placebo & Placebo
27 Completed Efficacy of Epoetin Alfa in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention: Drug: Epoetin alfa
28 Completed A First in Human Study of RT001 in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: RT001;   Drug: RT001 comparator
29 Recruiting A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)
Condition: Friedreich's Ataxia
Interventions: Procedure: Cardiac magnetic resonance imaging (CMR);   Procedure: Exercise-stress test;   Procedure: Echocardiography (ECHO);   Procedure: Cardiac-related blood studies
30 Completed Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: alpha-tocopherolquinone (A0001);   Drug: placebo
31 Recruiting An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention: Drug: Acetyl-L-Carnitine
32 Enrolling by invitation Safety, Tolerability and Efficacy of ACTIMMUNE Dose Escalation in Friedreich's Ataxia Study
Condition: Friedreich's Ataxia
Intervention: Drug: Interferon γ-1b
33 Active, not recruiting Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Interferon γ-1b;   Drug: Placebo
34 Completed
Has Results
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: VP 20629;   Drug: Placebo
35 Completed
Has Results
A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients
Condition: Friedreich's Ataxia
Interventions: Drug: idebenone;   Drug: Placebo
36 Enrolling by invitation Early and Longitudinal Assessment of Neurodegeneration in the Brain and Spinal Cord in Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention:
37 Unknown  A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients
Condition: Friedreich Ataxia.
Intervention: Drug: gamma interferon
38 Recruiting Biomarkers in Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention:
39 Enrolling by invitation STEADFAST Long-Term Safety Extension
Condition: Friedreich's Ataxia
Intervention: Drug: interferon γ-1b
40 Active, not recruiting Effect of Nicotinamide in Friedreich's Ataxia
Condition: Neurodegenerative Disorders
Intervention: Drug: nicotinamide

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-45) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.